Chromadex Corp Stock
Chromadex Corp Stock
A loss of -2.700% shows a downward development for Chromadex Corp.
Chromadex Corp is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 10 € there is a hugely positive potential of 85.19% for Chromadex Corp compared to the current price of 5.4 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -2.700% | -4.425% | -3.571% | -12.195% | 4.854% | 248.500% | 30.435% |
| Intellia Therapeutics Inc | -2.110% | 12.069% | -1.046% | -41.587% | -28.429% | -77.605% | -79.170% |
| Cardio3 Biosciences S.A. | - | -5.882% | -5.882% | -76.923% | -74.584% | -82.128% | -97.485% |
| Polynovo Ltd | 0.760% | 2.326% | 1.538% | -49.231% | -45.455% | -45.455% | -71.053% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat